Home LiteratureArticle Details
PMID: 10818680 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Review

The indispensable role of microenvironment in the natural history of low-grade B-cell neoplasms.

Advances in cancer research ·Vol. 79 ·2000-00-00 ·Pages 157-73

Ghia P, Caligaris-Cappio F

Abstract

Follicular lymphoma (FL) and B-cell chronic lymphocytic leukemia (B-CLL) are paradigmatic examples of lymphoid malignancies in which the relevant biological mechanisms are alterations in the control of apoptosis rather than an exaggerated proliferation. This explains why low-grade B-cell neoplasms still fail to be cured with current approaches. It is becoming increasingly clear that the defective apoptosis of FL and B-CLL has to be ascribed not only to intrinsic defects of the neoplastic cells, but also to extrinsic factors that influence their behavior. Malignant B cells retain the capacity to respond to microenvironmental signals, but have devised a monothematic responsiveness. They have a specific sensitivity to anti-apoptotic signals that favor their survival, whereas they seem to have become insensitive to pro-apoptotic signals. Bystander, nontumoral cells play a fundamental (though not sufficient) role both in the onset and in the progression of these diseases. The survival of leukemic cells appears to be dependent on direct cell-cell contacts. The localization of malignant B cells in bone marrow or neoplastic follicles is not a passive adhesion phenomenon but a crucial step for their survival. Bidirectional malignant lymphocyte-nontumoral cell interactions may lead to the amplification of a microenvironment able to inhibit the apoptosis of neoplastic B cells. The pressure of antigenic selection and the role of the tumor necrosis factor receptor family through the functional survival signal provided by CD40 together with the crippled death signal exerted by CD95 are new prominent characters on the stage.

MeSH Terms
Antigens, CD/physiology Apoptosis/physiology Bone Marrow/pathology CD40 Antigens/physiology CD40 Ligand CD79 Antigens Clonal Deletion Cytokines/physiology Dendritic Cells, Follicular/metabolism Fas Ligand Protein Germinal Center/physiology Humans Leukemia, Lymphocytic, Chronic, B-Cell/pathology Leukemic Infiltration Lymphoma, B-Cell/pathology Lymphoma, Follicular/pathology Lymphoma, Non-Hodgkin/pathology Membrane Glycoproteins/physiology Neoplasm Proteins/physiology Receptors, Antigen, B-Cell/physiology Receptors, Tumor Necrosis Factor/physiology Stromal Cells/physiology Tumor Necrosis Factor-alpha/physiology fas Receptor/physiology
Chemicals
Antigens, CD CD40 Antigens CD79 Antigens CD79A protein, human Cytokines FASLG protein, human Fas Ligand Protein Membrane Glycoproteins Neoplasm Proteins Receptors, Antigen, B-Cell Receptors, Tumor Necrosis Factor Tumor Necrosis Factor-alpha fas Receptor CD40 Ligand
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Ghia P
Department of Biomedical Sciences and Human Oncology, University of Torino, Italy.
Caligaris-Cappio F
Article Info
Journal
Advances in cancer research
Abbr.
Adv Cancer Res
ISSN
0065-230X
Published
2000-00-00
Pages
157-73
Language
English
Region
United States
NLM ID
0370416
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com